ZA9710587B - Dimesylate salts of neuropeptide y ligands - Google Patents
Dimesylate salts of neuropeptide y ligandsInfo
- Publication number
- ZA9710587B ZA9710587B ZA9710587A ZA9710587A ZA9710587B ZA 9710587 B ZA9710587 B ZA 9710587B ZA 9710587 A ZA9710587 A ZA 9710587A ZA 9710587 A ZA9710587 A ZA 9710587A ZA 9710587 B ZA9710587 B ZA 9710587B
- Authority
- ZA
- South Africa
- Prior art keywords
- neuropeptide
- ligands
- dimesylate
- salts
- dimesylate salts
- Prior art date
Links
- 101710151321 Melanostatin Proteins 0.000 title 1
- 102400000064 Neuropeptide Y Human genes 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3181596P | 1996-11-26 | 1996-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9710587B true ZA9710587B (en) | 1999-05-25 |
Family
ID=21861551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9710587A ZA9710587B (en) | 1996-11-26 | 1997-11-25 | Dimesylate salts of neuropeptide y ligands |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5914329A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0944611B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP3120861B2 (cg-RX-API-DMAC7.html) |
| AP (1) | AP9701148A0 (cg-RX-API-DMAC7.html) |
| AR (1) | AR010304A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE257472T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU4792497A (cg-RX-API-DMAC7.html) |
| BR (1) | BR9713538A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2272927C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69727155T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK0944611T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2213207T3 (cg-RX-API-DMAC7.html) |
| GT (1) | GT199700123A (cg-RX-API-DMAC7.html) |
| HN (1) | HN1997000154A (cg-RX-API-DMAC7.html) |
| HR (1) | HRP970640A2 (cg-RX-API-DMAC7.html) |
| ID (1) | ID18964A (cg-RX-API-DMAC7.html) |
| MA (1) | MA26450A1 (cg-RX-API-DMAC7.html) |
| PA (1) | PA8441701A1 (cg-RX-API-DMAC7.html) |
| PE (1) | PE17099A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT944611E (cg-RX-API-DMAC7.html) |
| TN (1) | TNSN97191A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1998023603A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA9710587B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001053477A1 (en) * | 2000-01-20 | 2001-07-26 | Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of neuropeptide y activity |
| EP2002827A2 (en) | 2001-12-05 | 2008-12-17 | The Baylor College Of Medicine | Methods and compositions for control of bone formation via modulation of sympathetic tone |
| WO2003057886A2 (en) | 2002-01-09 | 2003-07-17 | Arexis Ab | Detection of mutations |
| KR100716389B1 (ko) * | 2004-11-23 | 2007-05-11 | 동화약품공업주식회사 | Ｎ-히드록시－４－｛５－［４－（5－이소프로필－２－메틸－１,３－티아졸－4－일）페녹시］펜톡시｝벤즈아미딘 ２메탄술폰산염 |
| EP1877076A4 (en) * | 2005-04-15 | 2012-02-01 | Regenertech Pty Ltd | USE OF NEUROPEPTIDES Y (NPY) AND AGONIST OF ANTAGONISTS THEREOF FOR REGENERATING TISSUES |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996014307A1 (en) * | 1994-11-07 | 1996-05-17 | Pfizer Inc. | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
-
1997
- 1997-11-18 US US08/972,470 patent/US5914329A/en not_active Expired - Fee Related
- 1997-11-18 PA PA19978441701A patent/PA8441701A1/es unknown
- 1997-11-19 CA CA002272927A patent/CA2272927C/en not_active Expired - Fee Related
- 1997-11-19 EP EP97910602A patent/EP0944611B1/en not_active Expired - Lifetime
- 1997-11-19 BR BR9713538A patent/BR9713538A/pt not_active Application Discontinuation
- 1997-11-19 AT AT97910602T patent/ATE257472T1/de not_active IP Right Cessation
- 1997-11-19 ES ES97910602T patent/ES2213207T3/es not_active Expired - Lifetime
- 1997-11-19 DK DK97910602T patent/DK0944611T3/da active
- 1997-11-19 PT PT97910602T patent/PT944611E/pt unknown
- 1997-11-19 WO PCT/IB1997/001465 patent/WO1998023603A1/en not_active Ceased
- 1997-11-19 DE DE69727155T patent/DE69727155T2/de not_active Expired - Fee Related
- 1997-11-19 JP JP10524469A patent/JP3120861B2/ja not_active Expired - Fee Related
- 1997-11-19 AU AU47924/97A patent/AU4792497A/en not_active Abandoned
- 1997-11-19 PE PE1997001052A patent/PE17099A1/es not_active Application Discontinuation
- 1997-11-20 AP APAP/P/1997/001148A patent/AP9701148A0/en unknown
- 1997-11-24 AR ARP970105494A patent/AR010304A1/es unknown
- 1997-11-25 ID IDP973762A patent/ID18964A/id unknown
- 1997-11-25 TN TNTNSN97191A patent/TNSN97191A1/fr unknown
- 1997-11-25 MA MA24872A patent/MA26450A1/fr unknown
- 1997-11-25 GT GT199700123A patent/GT199700123A/es unknown
- 1997-11-25 ZA ZA9710587A patent/ZA9710587B/xx unknown
- 1997-11-26 HN HN1997000154A patent/HN1997000154A/es unknown
- 1997-11-26 HR HR60/031,815A patent/HRP970640A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69727155D1 (de) | 2004-02-12 |
| DK0944611T3 (da) | 2004-04-13 |
| US5914329A (en) | 1999-06-22 |
| DE69727155T2 (de) | 2004-07-08 |
| HRP970640A2 (en) | 1998-10-31 |
| AP9701148A0 (en) | 1998-01-31 |
| EP0944611A1 (en) | 1999-09-29 |
| CA2272927A1 (en) | 1998-06-04 |
| JP3120861B2 (ja) | 2000-12-25 |
| ID18964A (id) | 1998-05-28 |
| WO1998023603A1 (en) | 1998-06-04 |
| CA2272927C (en) | 2003-02-04 |
| PE17099A1 (es) | 1999-02-19 |
| GT199700123A (es) | 1999-05-19 |
| ES2213207T3 (es) | 2004-08-16 |
| PT944611E (pt) | 2004-04-30 |
| MA26450A1 (fr) | 2004-12-20 |
| HN1997000154A (es) | 1999-02-09 |
| TNSN97191A1 (fr) | 2005-03-15 |
| AR010304A1 (es) | 2000-06-07 |
| JP2000505110A (ja) | 2000-04-25 |
| BR9713538A (cg-RX-API-DMAC7.html) | 2000-03-21 |
| EP0944611B1 (en) | 2004-01-07 |
| PA8441701A1 (es) | 2000-05-24 |
| ATE257472T1 (de) | 2004-01-15 |
| AU4792497A (en) | 1998-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9602294D0 (en) | Heterocyclic compounds | |
| GB9617305D0 (en) | Heterocyclic compounds | |
| AU4792497A (en) | Dimesylate salts of neuropeptide y ligands | |
| GB9413758D0 (en) | Heterocyclic compounds | |
| GB9401921D0 (en) | Heterocyclic compounds | |
| GB9401994D0 (en) | Heterocyclic compounds | |
| EP0900204A4 (en) | HETEROCYCLIC CONNECTIONS | |
| GB9404942D0 (en) | Heterocyclic compound | |
| EP0912183A4 (en) | HETEROCYCLIC COMPOSITIONS | |
| EP0900217A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EP0900219A4 (en) | HETEROCYCLIC COMPOUNDS | |
| EG20790A (en) | Heterocyclic compounds | |
| GB9404716D0 (en) | Heterocyclic compounds | |
| GB9419342D0 (en) | Heterocyclic compounds | |
| GB9419083D0 (en) | Heterocyclic compounds | |
| GB9424260D0 (en) | Heterocyclic compounds | |
| GB9420700D0 (en) | Heterocyclic compounds | |
| GB9404721D0 (en) | Heterocyclic compounds | |
| GB9425828D0 (en) | Heterocyclic compounds | |
| GB9424263D0 (en) | Heterocyclic compounds | |
| GB9404734D0 (en) | Heterocyclic compounds | |
| ZA9531B (en) | Heterocyclic compounds | |
| GB9420702D0 (en) | Heterocyclic compounds | |
| GB9404719D0 (en) | Heterocyclic compounds | |
| IL115269A0 (en) | Heterocyclic compounds |